Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 12.2467 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 12.1392 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 12.3491 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 12.5531 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 12.4148 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 12.0542 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 11.8948 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 12.4258 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 12.5665 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 12.3074 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 12.0808 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 12.4454 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 12.4342 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 12.3785 | 99 |